Metlife Inc

Company facts

Industry

Life Insurance

Headquarters

New York, New York

Most recent report

10-Q, filed Nov 6, 2026

Incorporated

Delaware

Filings on record

1,004+ filings

On EDGAR

CIK 1099219

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Sep 2026 10-Q

SECSift found 3 of 11 sections worth reading, with 3 positive, 8 notable, and 2 negative flags.

• Financial Statements (Item 1)

  Financial statements and notes with material balance-sheet and cash-flow details.
  Notable

  • Pending sale of MetLife Ukraine with $65M impairment recorded in nine months ended Sep 30, 2026.
  • Gross unrealized losses on fixed-maturity AFS securities without ACL rose $15.8B to $43.9B due to higher interest rates.
  • Related-party reinsurance with Chariot Re grew: receivables $11.9B and funds withheld liability $12.3B at Sep 30, 2026.

• Management's Discussion (Item 2)

  Full MD&A with segment results, investment portfolio, liquidity, and capital actions.
  Positive

  • Net income available to common shareholders rose to $2.4B in Q3 2026 from $0.8B in Q3 2025.
  • Adjusted earnings available to common shareholders rose to $1.8B in Q3 2026 from $1.6B in Q3 2025.
  Notable

  • Strategic Reorganization in Q4 2025: MIM became a segment, MetLife Holdings removed, changes applied retrospectively.
  • Acquired PineBridge Investments in December 2025, driving MIM other revenue increase of 34% in Q3 2026.
  • RIS adjusted premiums, fees and other revenues surged 66% in Q3 2026, driven by UK funded reinsurance and longevity reinsurance.
  • Latin America adjusted premiums, fees and other revenues rose 22% in Q3 2026, driven by strong sales across the region.
  Negative

  • Actuarial assumption review resulted in a $86M loss in Q3 2026 vs a $102M gain in Q3 2025, a $188M swing.
  • Real estate impairment loss jumped to $214M for nine months ended Sep 2026 from $18M a year ago.

• Unregistered Sales and Repurchases (Item 2)

  New $3B buyback authorization in August 2026; 6.8M shares repurchased in Q3 2026.
  Positive

  • Board authorized $3.0B additional buyback in August 2026, signaling strong capital return.
  Notable

  • $3.0B remaining authorization at September 30, 2026, provides substantial future buyback capacity.

What changed: Sep 2026 vs. Jun 2026

About 5% of MET's Sep 2026 10-Q is new information. 57 paragraphs were added, 331 changed, and 57 removed. Below are the most important lines SECSift identified.

• Item 2 133
• Item 1 100
• Item 6 28
• Item 4 1
• Item 5 1